These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 31408440)
1. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma. Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas. Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837 [TBL] [Abstract][Full Text] [Related]
3. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas. Wu Y; Peng Z; Gu S; Wang H; Xiang W Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas. Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839 [TBL] [Abstract][Full Text] [Related]
5. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas. Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L Front Immunol; 2020; 11():603341. PubMed ID: 33363544 [TBL] [Abstract][Full Text] [Related]
6. RNA processing genes characterize RNA splicing and further stratify colorectal cancer. Lu X; Zhou Y; Meng J; Jiang L; Gao J; Cheng Y; Yan H; Wang Y; Zhang B; Li X; Yan F Cell Prolif; 2020 Aug; 53(8):e12861. PubMed ID: 32596958 [TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic value of mRNAs in lower grade glioma with MGMT promoter methylated. Wang W; Li J; Lin F; Guo J; Zhao J J Clin Neurosci; 2020 May; 75():45-51. PubMed ID: 32229069 [TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma. Zhao J; Wang L; Wei B Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843 [TBL] [Abstract][Full Text] [Related]
9. Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas. Yang Y; Chen X; Sun J; Chen S; Yang C; Ma Q; Yang J Sci Rep; 2021 Sep; 11(1):19493. PubMed ID: 34593910 [TBL] [Abstract][Full Text] [Related]
10. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas. Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476 [TBL] [Abstract][Full Text] [Related]
11. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma. Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K Front Oncol; 2020; 10():1119. PubMed ID: 32974125 [No Abstract] [Full Text] [Related]
12. Prognostic value of γ-aminobutyric acidergic synapse-associated signature for lower-grade gliomas. Jiang H; Sun Z; Li F; Chen Q Front Immunol; 2022; 13():983569. PubMed ID: 36405708 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling. Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas. Yan D; Zhao Q; Du Z; Li H; Geng R; Yang W; Zhang X; Cao J; Yi N; Zhou J; Tang Z Sci Rep; 2022 Apr; 12(1):6698. PubMed ID: 35461367 [TBL] [Abstract][Full Text] [Related]
15. A novel risk score model based on fourteen chromatin regulators-based genes for predicting overall survival of patients with lower-grade gliomas. Zhang Y; Yu B; Tian Y; Ren P; Lyu B; Fu L; Chen H; Li J; Gong S Front Genet; 2022; 13():957059. PubMed ID: 36246611 [No Abstract] [Full Text] [Related]
16. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
17. Identification of a three-long non-coding RNA signature for predicting survival of temozolomide-treated isocitrate dehydrogenase mutant low-grade gliomas. Li R; Chen W; Mao P; Wang J; Jing J; Sun Q; Wang M; Yu X Exp Biol Med (Maywood); 2021 Jan; 246(2):187-196. PubMed ID: 33028081 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas. Liu J; Li G Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort. Liu WR; Li CY; Xu WH; Liu XJ; Tang HD; Huang HN Aging (Albany NY); 2020 Jul; 12(13):13684-13700. PubMed ID: 32658870 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases. Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]